Endocrinology, Vol 107, 270-273, Copyright © 1980 by Endocrine Society

ARTICLES

Direct stimulation of bone resorption by epidermal growth factor

LG Raisz, HA Simmons, AL Sandberg and E Canalis

Epidermal growth factor, isolated from mouse submaxillary glands (mEGF) and human urine (hEGF; urogastrone), and fibroblast growth (FGF) have been tested for their effect on bone resorption by measuring the release of previously incorporated 45Ca from cultured fetal rat long bone shafts. mEGF produced significant but slow stimulation of bone resorption which was maximal at 30 ng/ml and was not blocked by indomethacin, flufenamic acid, or R0 20-5720, structurally unrelated inhibitors of prostaglandins synthesis. mEGF increased thymidine incorporation in long bones at 1 ng/ml, a concentration which did not stimulate resorption. hEGF at 3-30 ng/ml produced a more rapid stimulation of resorption, which was also unaffected by inhibition of prostaglandin cyclooxygenase. Neither mEGF nor hEGF increased the concentration of prostaglandin E in the medium after 5 days of culture. FGF failed to stimulate resorption at concentrations of up to 1000 ng/ml. We conclude the EGF, but not FGF, is a direct stimulator of bone resorption. In contrast to the previously reported findings in mouse calvaria, this stimulation is not dependent on prostaglandin synthesis. Since there is abundant hEGF in human urine, this factor could be responsible for the calcium-mobilizing activity recently found in human urine concentrates.

This article has been cited by other articles:

				J. Zhu, X. Jia, G. Xiao, Y. Kang, N. C. Partridge, and L. Qin IMPLICATIONS FOR OSTEOLYTIC BONE METASTASES J. Biol. Chem., September 14, 2007; 282(37): 26656 - 26664. [Abstract] [Full Text] [PDF]

				C. J. Xian Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth Endocr. Rev., May 1, 2007; 28(3): 284 - 296. [Abstract] [Full Text] [PDF]

				L. Qin, J. Tamasi, L. Raggatt, X. Li, J. H. M. Feyen, D. C. Lee, E. DiCicco-Bloom, and N. C. Partridge Amphiregulin Is a Novel Growth Factor Involved in Normal Bone Development and in the Cellular Response to Parathyroid Hormone Stimulation J. Biol. Chem., February 4, 2005; 280(5): 3974 - 3981. [Abstract] [Full Text] [PDF]

				K. Wang, H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu Epidermal Growth Factor Receptor-deficient Mice Have Delayed Primary Endochondral Ossification Because of Defective Osteoclast Recruitment J. Biol. Chem., December 17, 2004; 279(51): 53848 - 53856. [Abstract] [Full Text] [PDF]

				A. Gurlek, M. R. Pittelkow, and R. Kumar Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation Endocr. Rev., December 1, 2002; 23(6): 763 - 786. [Abstract] [Full Text] [PDF]

				J.-W. Xu, J. Ma, T.-F. Li, E. Waris, A. Alberty, S. Santavirta, and Y. T Konttinen Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty Ann Rheum Dis, October 1, 2000; 59(10): 822 - 827. [Abstract] [Full Text]

				K. Ibbotson, D. Twardzik, S. D'Souza, W. Hargreaves, G. Todaro, and G. Mundy Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha Science, May 24, 1985; 228(4702): 1007 - 1009. [Abstract] [PDF]

				K. Ibbotson, S. D'Souza, K. Ng, C. Osborne, M Niall, T. Martin, and G. Mundy Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy Science, September 23, 1983; 221(4617): 1292 - 1294. [Abstract] [PDF]

				S.-Y. Chan and R. W.-C. Wong Expression of Epidermal Growth Factor in Transgenic Mice Causes Growth Retardation J. Biol. Chem., December 1, 2000; 275(49): 38693 - 38698. [Abstract] [Full Text] [PDF]